載入...
Phase II study of temozolomide monotherapy in patients with extrapulmonary neuroendocrine carcinoma
Extrapulmonary neuroendocrine carcinoma (EPNEC) is a lethal disease with a poor prognosis. Platinum‐based chemotherapy is used as the standard first‐line treatment for unresectable EPNEC. Several retrospective studies have reported the results of the utilization of temozolomide (TMZ) as a drug for t...
Na minha lista:
| 發表在: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8088944/ https://ncbi.nlm.nih.gov/pubmed/33453146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14811 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|